Skip Navigation



Human Molecular Genetics Advance Access published online on August 8, 2005
Human Molecular Genetics, doi:10.1093/hmg/ddi301
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrowOA All Versions of this Article:
14/18/2671    most recent
ddi301v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Winrow, C. J.
Right arrow Articles by Barlow, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winrow, C. J.
Right arrow Articles by Barlow, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
Received May 16, 2005
Revised July 10, 2005
Accepted August 1, 2005

Article

Aberrant recombination involving the granzyme locus occurs in Atm-/-T-Cell Lymphomas

Christopher J. Winrow 1, Daniel G. Pankratz 1, Cecile Rose T. Vibat 2, T. J. Bowen 3, Marie A. Callahan 2, Amy J. Warren 2, Brian S. Hilbush 2, Anthony Wynshaw-Boris 3, Karl W. Hasel 2, Zoë Weaver 4, David J. Lockhart 5, and Carrolee Barlow 6*

1 The Salk Institute for Biological Studies, The Laboratory of Genetics, 10010 North Torrey Pines Road, La Jolla, California 92037
2 Digital Gene Technologies, Inc., 11149 North Torrey Pines Road, La Jolla, California 92037
3 University of California, San Diego; Departments of Pediatrics and Medicine, School of Medicine, La Jolla, California 92093-0627
4 Avalon Pharmaceuticals, Inc., 19 Firstfield Road, Gaithersburg, MD 20878
5 The Salk Institute for Biological Studies, The Laboratory of Genetics, 10010 North Torrey Pines Road, La Jolla, California 92037; Ambit Biosciences, 4215 Sorrento Valley Boulevard, San Diego, CA 92121
6 The Salk Institute for Biological Studies, The Laboratory of Genetics, 10010 North Torrey Pines Road, La Jolla, California 92037; Brain Cells Inc., 10835 Road to the Cure, San Diego, CA 92121

* To whom correspondence should be addressed.
Carrolee Barlow, E-mail: cbarlow{at}braincellsinc.com


  Abstract

Ataxia Telangiectasia (A-T) is an autosomal recessive disease caused by loss of function of the serine/threonine protein kinase ATM. A-T patients have a 250-700 fold increased risk of developing lymphomas and leukemias, which are typically highly invasive and proliferative. In addition, a subset of adult acute lymphoblastic leukemias and aggressive B-cell chronic lymphocytic leukemias that occur in the general population show loss of heterozygosity (LOH) for ATM. To define the specific role of ATM in lymphomagenesis we studied T-cell lymphomas isolated from mice with mutations in ATM and/or p53 using cytogenetic analysis and mRNA transcriptional profiling. The analyses identified genes misregulated as a consequence of the amplifications, deletions and translocation events arising as a result of ATM loss. A specific recurrent disruption of the granzyme gene family locus was identified resulting in an aberrant granzyme B/C fusion product. The combined application of cytogenetic and gene expression approaches identified specific loci and genes that define the pathway of initiation and progression of lymphoreticular malignancies in the absence of ATM.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.